Synergy Resources Corporation (NYSEMKT:SYRG)

Synergy Resources Corporation operates as an oil and natural gas company engaged in the exploration and production of oil and natural gas in the Denver-Julesburg Basin. Synergy Resources Corporation has its corporate offices located in Platteville, Colorado.

Synergy Resources Corporation (NYSEMKT:SYRG)’s Financial Overview

Synergy Resources Corporation (NYSEMKT:SYRG) surged 18.33% yesterday to close its trading session at $9.49. The company has 1 year Price Target of $9.6. Synergy Resources Corporation has 52-Week high of $11.42 and 52-Week Low of $5.01. The stock touched its 52-Week High on Dec 3, 2015 and 52-Week Low on Feb 8, 2016. The stock traded with the volume of 12.16 Million shares yesterday. The firm shows the market capitalization of $1.9 Billion.

Synergy Resources Corporation (NYSEMKT:SYRG) reported its last quarterly earnings on Sep 16 where the firm reported its Actual EPS of $0.03/share against the analyst consensus estimate of $-0.01/share. The difference between the actual and expected EPS is $0.04 a share with a surprise factor of 400%.

The firm is trading with SMA20 of 19.81 Percent, SMA50 of 29.72 Percent and SMA200 of 36.65 percent. Synergy Resources Corporation has P/S value of 18.55 while its P/B value stands at 2.29. Similarly, the company has Return on Assets of 0 percent, Return on Equity of 0 percent and Return on Investment of -22.1 Percent. The company shows Gross Margin and Operating Margin of 74.3 percent and 0 percent respectively.

Many brokerage firms are involved in issuing their ratings on Synergy Resources Corporation (NYSEMKT:SYRG). On 28-Nov-16 KLR Group Downgrade Synergy Resources Corporation Stock  to Accumulate. Another firm also rated the stock on 25-Oct-16 where Wells Fargo Initiated the stock to Outperform.

The Stock currently has Analyst’ mean Recommendation of 1.8 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 21 analysts offering 12-month price forecasts for Synergy Resources Corp have a median target of 10.00, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +5.37% increase from the last price of 9.49.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Dynavax Technologies Corporation (NASDAQ:DVAX)

Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax’s clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.

Dynavax Technologies Corporation (NASDAQ:DVAX)’s Financial Outlook

The 3 analysts offering 12-month price forecasts for Dynavax Technologies Corp have a median target of 17.00, with a high estimate of 45.00 and a low estimate of 4.00. The median estimate represents a +295.35% increase from the last price of 4.30.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, Dynavax Technologies Corporation has a Consensus Recommendation of 2. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock fell -9.47% and closed its last trading session at $4.3. The company has the market capitalization of $165.72 Million. The stock has 52-week high of $29.86 and 52-Week low of $3.2. The firm touched its 52-Week high on Jan 8, 2016 and 52-Week low on Nov 14, 2016. The company has volume of 2.14 Million shares. The company has a total of 38.54 Million shares outstanding.

Dynavax Technologies Corporation (NASDAQ:DVAX) in the last quarter reported its actual EPS of $-0.9/share where the analyst estimated EPS was $-0.75/share. The difference between the actual and Estimated EPS is $-0.15. This shows a surprise factor of -20 percent.

The company has YTD performance of -82.2 percent. Beta for Dynavax Technologies Corporation stands at 1.97 while its ATR (average true range) is 0.79. The company has Weekly Volatility of 8.39%% and Monthly Volatility of 10.68%%.

Dynavax Technologies Corporation has distance from 20-day Simple Moving Average (SMA20) of -40.65%, Distance from 50-Day Simple Moving Average of -53.87 percent and Distance from 200-Day Simple Moving Average of -70.64%.

The Company currently has ROA (Return on Assets) of -65.9 percent, Return on Equity (ROE) of -78.6 Percent and Return on Investment (ROI) of -57.1% with Gross margin of 0 percent and Operating & Profit margin of 0% and 0% respectively.